Evidence map›Paper›PMID 34310861›Full record

ReviewPharmacology research & perspectives2021

Kidney damage from nonsteroidal anti-inflammatory drugs-Myth or truth? Review of selected literature.

Sylwester Drożdżal, Kacper Lechowicz, Bartosz Szostak, Jakub Rosik, Katarzyna Kotfis, Anna Machoy-Mokrzyńska, Monika Białecka, Kazimierz Ciechanowski, Barbara Gawrońska-Szklarz

Open access · goldAbstract readReview
In one paragraph

Review in Pharmacology research & perspectives, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 143 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Role of Mast Cells and Their Mediators in Chronic Kidney Diseases.International journal of molecular sciences · 2025
    Review
  19. Phytochemical Analysis and Phytometabolomic Profiling ofInternational journal of molecular sciences · 2025
    Article
  20. Effects of Long-Term Carprofen and Omeprazole Administration in C57BL/6J Mice.Journal of the American Association for Laboratory Animal Science : JAALAS · 2025
    Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sylwester DrożdżalDepartment of Pharmacokinetics and Monitored Therapy, Pomeranian Medical University, Szczecin, Poland.
Kacper LechowiczDepartment of Anaesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University, Szczecin, Poland.
Bartosz SzostakDepartment of Physiology, Pomeranian Medical University, Szczecin, Poland.ORCID 0000-0003-0502-6157
Jakub RosikDepartment of Physiology, Pomeranian Medical University, Szczecin, Poland.ORCID 0000-0001-7377-4566
Katarzyna KotfisDepartment of Anaesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University, Szczecin, Poland.
Anna Machoy-MokrzyńskaDepartment of Experimental and Clinical Pharmacology, Pomeranian Medical University, Szczecin, Poland.
Monika BiałeckaDepartment of Pharmacokinetics and Monitored Therapy, Pomeranian Medical University, Szczecin, Poland.
Kazimierz CiechanowskiDepartment of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, Szczecin, Poland.
Barbara Gawrońska-SzklarzDepartment of Pharmacokinetics and Monitored Therapy, Pomeranian Medical University, Szczecin, Poland.
Pomeranian Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely available drugs with anti-inflammatory and analgesic properties. Their mechanism of action is associated with the enzymes of the arachidonic acid cycle (cyclooxygenases: COX-1 and COX-2). The cyclooxygenase pathway results in the formation of prostanoids (prostaglandins [PGs], prostacyclins, and thromboxanes). It affects various structures of the human body, including the kidneys. Medical literature associates the usage of NSAIDs with acute kidney injury (AKI), tubulointerstitial nephritis (TIN), as well as nephrotic syndrome and chronic kidney disease (CKD). AKI associated with the chronic consumption of NSAIDs is mainly attributed to pharmacological polytherapy and the presence of cardiovascular or hepatic comorbidities. The pathomechanism of AKI and CKD is associated with inhibition of the biosynthesis of prostanoids involved in the maintenance of renal blood flow, especially PGE2 and PGI2. It is suggested that both COX isoforms play opposing roles in renal function, with natriuresis increased by COX-1 inhibition followed by a drop in a blood pressure, whereas COX-2 inhibition increases blood pressure and promotes sodium retention. TIN after NSAID use is potentially associated with glomerular basement membrane damage, reduction in pore size, and podocyte density. Therefore, nephrotic proteinuria and impairment of renal function may occur. The following article analyzes the association of NSAIDs with kidney disease based on available medical literature.

Indexed as

Acute Kidney InjuryAnimalsAnti-Inflammatory Agents, Non-SteroidalHumansNephritis, InterstitialRenal Insufficiency, ChronicAnti-Inflammatory Agents, Non-SteroidalAKICKDnephrotoxicityNSAIDs

Identifiers

PMID34310861
PMCPMC8313037
OpenAlexW3183246366

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.